Dr Anthony Fauci says US will not delay second doses of Covid vaccine

American infectious disease expert disagrees with UK’s plans to prioritise first doses

The American infectious disease expert Dr Anthony Fauci has said he does not agree with the UK’s approach of delaying the second dose of the Pfizer/BioNTech vaccine.

On Friday, Dr Fauci told CNN that the United States would not be following in the UK’s footsteps and would follow Pfizer and BioNTech’s guidance to administer the second dose of its vaccine three weeks after the first.

Continue reading...

Golden ticket: the lucky tourists sitting out coronavirus in New Zealand

Visitors from UK and North America tell of finding themselves with a pass to one of the best-rated pandemic responses in the world

For Christmas 2019 Efrain Vega de Varona gave his partner plane tickets to New Zealand – her dream holiday destination. It has proved a gift that keeps on giving.

A year later they are still in New Zealand, having decided to stay put at the end of their two-week holiday in mid-March rather than return to Los Angeles. “We’ve been living out of two suitcases for 10 months,” says Vega de Varona from their latest Airbnb rental (number 50-something this year) in Island Bay, Wellington.

Continue reading...

Coronavirus live news: EU rollout of Pfizer vaccine may be disrupted by supply issues, BioNTech warns

Latest updates: German biotech startup warns of ‘gaps’ in vaccine supply; re-analysis Covid tests in US raises questions about origin of B117 ‘UK strain’

India has asked China to allow two Indian cargo ships which have been stranded for months near two Chinese ports because of the pandemic to rapidly unload their cargoes or replace their 39 crew members.

“There is growing stress on the crew members on account of the long delay,” Indian external affairs ministry spokesman Anurag Srivastava said. “We expect that this assistance will be provided in an urgent, practical and time-bound manner, given the grave humanitarian situation that is developing onboard the ships.”

The UK economy begins 2021 on the back foot as record numbers of coronavirus infections and tougher restrictions cloud the outlook for growth and limit the chances of a rapid recovery from the country’s worst recession in 300 years.

There had been hopes that the arrival of successful Covid vaccines could prompt a rebound in activity. But with new government controls to combat the rising infection rate, the outlook is deteriorating.

Related: UK economic outlook for 2021: Covid surge deepens the gloom

Continue reading...

Questions hang over UK’s rollout of Oxford/AstraZeneca jab

Analysis: regulator surprises by approving 12-week gap between first and second shots of vaccine as well as Pfizer/BioNTech shot

It’s a pragmatic solution to an incredibly urgent problem – how to immunise very large numbers of people at risk from a rampaging variant of Covid-19 in the shortest possible time. The answer that government advisers have come up with is to give them all – more than 20 million of them – a single shot of the Oxford/AstraZeneca vaccine so that they have some protection and postpone the second dose to three months afterwards, when hopefully there will be plenty of vaccine available for boosters.

Related: How well does the Oxford vaccine work? What we know so far

Continue reading...

Science matters. The remarkable response to Covid has reminded us | Gideon Meyerowitz-Katz

While there have been setbacks, in Australia at least it would be hard to find many people distrusting of scientists

Being an epidemiologist in 2020 has been a very odd experience. This time last year, when I told people my job title, more than half the time I’d be met with a blank look and then the tentative question: “Is that … like a skin doctor?”.

Explaining that it was more like a spreadsheet doctor rarely went down that well.

Continue reading...

Coronavirus live news: more countries report suspected cases of new Covid variant

Latest updates: South Africa imposes tighter restrictions amid sharp increase in cases; UK told it must vaccinate 2 million people per week to avoid new wave

India has found six people who returned from the UK in recent weeks with the more infectious strain of the virus that has prompted border closures around the world, Reuters reports.

Nevertheless, the country’s daily increase in cases fell to a six-month low.

Hello and thank you for reading our live coverage. I’ll be with you for the next few hours. Here’s a brief summary of where we stand:

Continue reading...

I’m a consultant in infectious diseases. ‘Long Covid’ is anything but a mild illness | Joanna Herman

Nine months on from the virus, I am seriously debilitated. This is how the new NHS clinics need to help thousands of us

With the excitement of the Covid vaccine’s arrival, it may be easy to forget and ignore those of us with “long Covid”, who are struggling to reclaim our previous, pre-viral lives and continue to live with debilitating symptoms. Even when the NHS has managed the herculean task of vaccinating the nation, Covid-19 and the new mutant variants of the virus will continue to circulate, leaving more people at risk of long Covid. Data from a King’s College London study in September suggested as many as 60,000 people in the UK could be affected, but the latest statistics from the Office for National Statistics suggest it could be much higher.

I was acutely ill in March, though – like many people with long Covid – mine was defined as a “mild” case not requiring admission to hospital. Nine months on, I am seriously debilitated, with crashing post-exertional fatigue, often associated with chest pains. On bad days, my brain feels like it doesn’t want to function, even a conversation can be too much. I have no risk factors, I’m in my 50s, and have always been fit, but remain too unwell to work – ironically as a consultant in infectious diseases. Watching the pandemic unfold from the sidelines when I should have been working in the thick of it has only added to the frustration of my protracted illness.

Continue reading...

Scientists call for UK lockdown after rapid spread of Covid-19 variant

Stricter measures needed as cases of mutated virus, linked to UK travellers, are reported across globe

Cases of the new variant Covid-19 virus were confirmed in several European countries on Saturday, including Spain, Sweden and Switzerland. All were linked to people who had arrived from the UK.

Meanwhile, Japan has announced it is banning all new entries of foreign nationals from Monday following the discovery of the variant in travellers from the UK.

Continue reading...

Coronavirus live news: millions more wake up to tier 4 in England

Follow all the latest on the coronavirus pandemic across the world

The new variant of the coronavirus circulating in Britain has been detected in Sweden after a traveller from Britain fell ill on arrival and tested positive for it, the Swedish health agency said on Saturday.

A health agency official, Sara Byfors, told a news conference that the traveller, who was not identified, had kept isolated after arrival to Sweden and that no further positive cases had so far been detected.

Jordan has arrested a journalist over an article alleging that the coronavirus vaccine had arrived in the kingdom and that officials had received the jab, a judicial source said on Saturday.

“The state security court prosecutor ordered the arrest Thursday of journalist Jamal Haddad, editor of news website Al-Wakaai, for writing that government officials had been vaccinated against the coronavirus,” the source said.

Continue reading...

Ten reasons why we got Covid-19 vaccines so quickly without ‘cutting corners’ | Adam Finn

The speedy rollout is thanks to a combination of foresight, hard work and lucky breaks

The speed at which effective Covid-19 vaccines have come through to authorisation has caused surprise. Compared with previous vaccines, the process has been very fast and so, naturally, people are asking how can it have happened without some kind of compromise on standards and care. Explaining it all as simply a result of the wonders of the latest scientific advances seems vague. So how has it actually come about? In reality, there are at least 10 reasons: some are about good planning, some good science and some just good luck.

Continue reading...

UK scientists trial drug to prevent infection that leads to Covid

Exclusive: Antibody therapy could confer instant immunity to Covid-19 on at-risk groups

British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going on to develop the disease Covid-19, which experts say could save many lives.

The antibody therapy would confer instant immunity against the disease and could be given as an emergency treatment to hospital inpatients and care home residents to help contain outbreaks.

Continue reading...

South African Covid-19 variant may be ‘more effective at spreading’

Research still to confirm threat posed but variant does not appear to provoke more serious symptoms

The South African variant of Covid-19, two cases of which have now been detected in the UK, is likely to be more transmissible, may hit young people harder, and may be slightly more resistant to vaccines, scientists in South Africa believe.

However, research is still continuing to confirm the threat posed by the variant, which does not appear to provoke more serious symptoms or require different treatment.

Continue reading...

Fears UK aid cuts could undermine research on deadliest diseases

Exclusive: experts sign letter warning against slashing spending on public-private programmes

Experts fear a push to cut the UK’s aid budget will slash spending on global health research, handicapping international public-private programmes that have helped combat the world’s deadliest diseases over the last decade.

In a letter addressed to the foreign secretary, Dominic Raab, last week, prominent parliamentarians sought reassurance that the planned cuts would not lead to “dramatic reductions” in investment for devastating diseases such as tuberculosis, malaria, Aids and a clutch of neglected tropical diseases.

Continue reading...

What do we know about the two new Covid-19 variants in the UK?

One appears to have arisen in Kent, the other brought in from South Africa. Both are highly transmissible

Two new variants of Covid-19 have been identified as of concern in the UK, both said to be more transmissible than the previously dominant version. Here’s what we know so far.

Continue reading...

Scorned scientist now vindicated in her work on how to treat stroke

Anne Abbott challenged medical establishment and faced ‘shocking’ rebuffs

Anne Abbott is a scientist on a mission. She believes large numbers of debilitating strokes can be prevented without surgical interventions. Lifestyle changes and medication alone can make massive improvements to people at risk from the thickening of their arteries.

It is not an attitude that has endeared her to the medical establishment, however. For years, it has attempted to block her work while instead pressing for increasing use of carotid surgery and stents, she told the Observer last week.

Continue reading...

A Christmas pandemic like no other? They thought that in 1918

The post-first world war flu outbreak also came in waves and led to school closures and face-mask rows

This is not the first time that a pandemic has gripped the holiday season. In December 1918, preparations for the first Christmas without war in four years took place in the midst of the worst pandemic since the Black Death.

The 1918-19 influenza, like Covid-19, came in waves. The deadliest began in autumn, peaked in late November and continued through the first weeks of December. It struck hundreds of millions and killed tens of millions worldwide.

Continue reading...

Covid is a chance to build a world where everyone has access to basic vaccines | David Miliband and Anuradha Gupta

Preventable diseases still plague those missing out on vaccines. Efforts to halt coronavirus could help crack this issue

The massive public, private and foundation investments in a coronavirus vaccine are producing results at a record pace. And countries are reacting accordingly. A recent global assessment of purchasing agreements for Covid-19 vaccines reveals that high-income countries, as well as a few middle-income countries with high manufacturing capacity, have already bought enough doses for their populations.

But delivery of the vaccine needs a new level of focus. This is especially the case for populations in poor and war-torn countries, where the health system is weak or nonexistent. Even before the pandemic, approximately 20 million infants a year, often some of the most vulnerable in the world, were missing out on basic vaccines. For example, there are estimated to be more than 10.6 million children in the world’s poorest countries who in 2019 did not receive even a first dose of a diphtheria-pertussis-tetanus vaccine (DPT).

Continue reading...

UK Covid live: tier 3 rules extended across southern England as secondary schools face staggered January return

Latest updates: ‘vast majority’ of areas currently in tier 3 will remain there; secondary school pupils’ return to class in England will be staggered

The Department of Health has released a written ministerial statement giving the reasons for the decisions taken today about why areas in England are staying in, or moving from, particular tiers. It’s here - although the version up at the moment only covers the north-west, the north-east and London.

The government is to provide interim cover for EU holiday healthcare costs for people who require routine hospital treatment such as dialysis and chemotherapy in the event there is no Brexit deal to replace the current European Health Care Insurance Scheme (EHIC).

In a written ministerial statement Edward Argar, a health minister, said:

This government will introduce the scheme with the intention that it is used by individuals who are certain to require treatment while abroad, such as regular dialysis, oxygen therapy or certain types of chemotherapy. The government recognises that these ongoing, routine treatment costs can be expensive, and makes travelling abroad extremely challenging for many people.

Continue reading...

British American Tobacco wins approval to test Covid vaccine on humans

Treatment grown on tobacco plants gets US backing for clinical study

British American Tobacco has moved a step closer to producing a vaccine for coronavirus using tobacco plants, as it won approval in the US to begin testing on humans.

The company behind cigarette brands including Lucky Strike, Rothmans and Benson & Hedges said the US Food & Drug Administration had given it clearance to begin a clinical study with adult volunteers.

Continue reading...

The great project: how Covid changed science for ever

The emergence of a novel coronavirus prompted a wave of global collaboration that has led to vaccines, treatments and the promise of new discoveries

For scientists, 5 January was a turning point in the fight against the coronavirus. That day, a team led by Prof Yong-Zhen Zhang at Fudan University in Shanghai sequenced the genetic code of the virus behind Wuhan’s month-long pneumonia outbreak. The process took about 40 hours. Having analysed the code, Zhang reported back to the Ministry of Health. The pathogen was a novel coronavirus similar to Sars, the deadly virus that sparked an epidemic in 2003. People should take precautions, he warned.

The Chinese government had imposed an embargo on information about the outbreak and Zhang and his co-workers were under pressure not to publish the code. The blackout couldn’t hold. On 8 January, news broke about the nature of the pathogen and was confirmed a day later by Chinese authorities. To sit on the code now seemed ridiculous.

Continue reading...